Reminder! Call for CTA@Boston Applications - Deadline is June 12
Are you a High Potential Canadian ICT or Life Science SME ready to grow in the US Boston Market? We can help.
CTA@Boston is an award-winning program that connects Canadian ICT and Life Science companies to US clients, strategic partners and investors, emphasizing aggressive business development and growth.
The Canadian Technology Accelerator in Boston (CTA@Boston) is looking for fast growing ICT and Life Science candidates for the Fall 2017 cohort.
Application Deadline: June 12, 2017
Formation Biologics Announces Dosing of First Patient in a Phase I/IIa Trial of AVID100, Closing of Series B Financing, and Appointment of Dr. Anthony Tolcher to its Board of Directors
Formation Biologics, a clinical stage biopharmaceutical company, today announces the start of a multi-center, Phase I/IIa trial evaluating AVID100 in patients with epidermal growth factor receptor (EGFR)-expressing malignancies. The trial commenced at South Texas Accelerated Research Therapeutics in San Antonio, Texas.
CAAP Company: MyndTec Wins Ontario Centres of Excellence's (OCE) $20,000 Accessibility Tech Pitch Competition
MyndTec Wins Ontario Centres of Excellence's (OCE) $20,000 Accessibility Tech Pitch Competition
OBIO® Releases Report on Actionable Strategies to Establish a World-leading Bioscience Industry in the Province of Ontario.
OBIO® released a report on actionable strategies to establish a world-leading bioscience industry in the province of Ontario.
CAAP Company: Conavi Medical Receives 510(k) Clearance for Foresight Intracardiac Echocardiography (ICE) System now Equipped with Color Doppler, 2D and 3D Measurements, and Enhanced 3D Visualization
Toronto, May 1 2017 Conavi Medical Inc. announced their 510(k) clearance from the FDA for its Foresight ICE System expanded feature set.
Genomic Applications Partnership Program (GAPP)
GAPP is a Genome Canada funding program for Receptors (such as industry, government, not-for-profit, other organizations) working with an academic partner to validate an ‘omics-driven technology.
Expressions of Interest are due to Ontario Genomics on May 15th.
OBIO Partner: StarFish Medical's 2nd Annual Digital Health Survey
StarFish Medical's 2nd Annual Digital Health Survey
OBIO Member: Focal Healthcare Inc Receives Health Canada Approval
OBIO Member, Focal Healthcare Inc, has been granted a Class II Health Canada Medical Device License for its targeted prostate biopsy device, Fusion Bx
CAAP Company: Swift Medical Closes Over Subscribed Funding Round
OBIO CAAP 2016 company, Swift Medical, a market leader in machine vision and machine learning platforms for mobile health and data analytics, today announced completing a rounds of funding led by Montreal's Real Ventures with participation from Relay Ventures, Lumira Capital, MaRS IAF and a strategic partner.
OBIO + JLABS Team Up for You
OBIO has partnered with JLABS Toronto to provide access to all JLABS Toronto Events for OBIO Members for FREE!
MaRS Innovation and KHIDI Commence Joint Research Initiatives
MaRS Innovation (MI) and its South Korean partner, Korea Health Industry Development Institute (KHIDI), continue to build on the five-year global partnership agreement signed in December 2016 during Premier Wynne’s mission to the Republic of Korea.
OBIO CAAP Company: Intronix Technologies Launches Myoguide DOC
OBIO CAAP 2014 company, Intronix Technologies, will be launching their "Myoguide DOC"
Steadiwear Wins Again!
OBIO Member company, Steadiwear, wins again!
CAAP Companies: Eve Medical & QoC Health in The Globe and Mail
Former OBIO CAAP companies, Eve Medical and QoC Health, have been quoted in The Globe and Mail this week
OBIO Member: CCAB Signs Agreement with Pionyr Immunotherapeutics Inc.
OBIO Member, the Centre for the Commercialization of Antibodies and Biologics (CCAB)has signed an Agreement with Pionyr Immunotherapeutics Inc.
OBIO Member: Steadiwear Wins RESI on MaRS Innovation Challenge
OBIO Member, Steadiwear, has won 1st Place in the RESI on MaRS Innovation Challenge.
CAAP Companies: Pathcore & WinterLight Labs Announced as HTF Recipients
OBIO CAAP companies, Pathcore and WinterLight Labs have both been announced as recipients of the Ontario Health Technology Fund!
OBIO CAAP® 2017 Kicks Off Just As Toronto Health Innovation Week Launches
OBIO kicked off its 2017 Capital Access Advisory Program (CAAP®) on March 29, 2017, hosted at sponsor Norton Rose Fulbright LLP (NRF) Canada, just as Toronto’s first inaugural Health Innovation Week launches.
Call for Proposals: Hamilton Health Sciences & IBM
Hamilton Health Sciences and IBM are seeking proposals for exciting, innovative new projects aimed at improving the delivery of health care.
Pre-CAAP Company: MedStack Turns 2
OBIO Pre-CAAP company, MedStack, has turned 2!